Advances in MPN Management: Insights From MANIFEST-2 and Beyond

An expert discusses insights from MAJIC-PV, MANIFEST-2, and other relevant trials and how these studies help advance the management of myeloproliferative neoplasms (MPNs).

EP: 1.A 68-Year-Old Woman Diagnosed With Primary Myelofibrosis

EP: 2.Molecular Profiling in MPNs: Enhancing Diagnostic Insights

EP: 3.JAK V617F Monitoring and Risk Assessment Tools: Optimizing Treatment Decisions in MPN

EP: 4.Treatment Insights From RESPONSE: Ruxolitinib Therapy in Hydroxyurea-Resistant/Intolerant Disease

Now Viewing

EP: 5.Advances in MPN Management: Insights From MANIFEST-2 and Beyond

EP: 6.Quality of Life in MPNs: Patient-Centered Factors That Shape Treatment Approaches

Video content above is prompted by the following:

Please share your insights from the following trials and how they help in advancing MPN management:

1. MAJIC-PV
2. MANIFEST-2
3. Others

Recent Videos